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Inﬂammation in Women With Angina in the
Absence of Coronary Atherosclerosis
The Dallas Heart Study
Kamakki Banks, MD, MPH,†‡ Divijani Puttagunta, MD,† Sabina Murphy, MS,*
Monica Lo, MD,†‡ Darren K. McGuire, MD, MHSC,*†‡ James A. de Lemos, MD,*†‡
Alice Y. Chang, MD, MSCS,*†§ Scott M. Grundy, MD, PHD,* Amit Khera, MD, MSC*†‡
Dallas, Texas
O B J E C T I V E S We sought to evaluate the relationship between angina and coronary artery calcium
(CAC) in women, and among women without CAC, the associations between angina and clinical,
vascular, and inﬂammatory factors.
B A C KG ROUND Angina in women without coronary atherosclerosis is associated with signiﬁcant
morbidity, yet its determinants are poorly understood.
METHOD S Women ages 30 to 65 years from the Dallas Heart Study, a multiethnic probability
sample of Dallas County residents, who completed a Rose angina questionnaire and had complete
data for CAC by computed tomography were selected for this analysis. Soluble intercellular
adhesion molecule-1, soluble vascular cell adhesion molecule-1, high sensitivity C-reactive protein,
monocyte chemoattractant protein-1 and aortic compliance by magnetic resonance imaging were
measured.
R E S U L T S Among the 1,480 women in this cohort (mean age 45 years, 49% African-American),
angina was present in 6.9% but was not associated with CAC (19% CAC prevalence with angina vs. 15%
without, p  0.2). Among women without CAC, angina was related to variables reﬂecting obesity and
insulin resistance and was independently associated with African-American ethnicity, premature family
history of myocardial infarction, and waist circumference (all p  0.05). Such women with angina also
had higher levels of soluble intercellular adhesion molecule-1 (668 vs. 592 ng/ml, p  0.02) and soluble
vascular cell adhesion molecule-1 (1,106 vs. 968 ng/ml, p  0.01) and reduced aortic compliance (mean
22 vs. 26 ml/mm Hg, p  0.007) than such women without angina. Conversely, there was no difference
in C-reactive protein or monocyte chemoattractant protein-1 levels for women with and without angina
(p  not signiﬁcant, each).
CONC L U S I O N S Angina among women in the general population is common and is not
associated with subclinical atherosclerosis. Additionally, angina in the absence of subclinical atheroscle-
rosis is not related to many traditional atherosclerotic risk factors but is associated with clinical,
inﬂammatory, and vascular factors that reﬂect endothelial dysfunction and vascular stiffness, suggesting
a distinct vascular etiology and alternative potential therapeutic targets. (J Am Coll Cardiol Img 2011;
4:65–73) © 2011 by the American College of Cardiology Foundation
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66ngina in women is a morbid condition for
which the determinants are poorly character-
ized. More than 50% of women with an-
gina may have normal or near-normal
oronary arteries visualized at coronary angiogra-
hy, a rate much higher than is observed among
en (1). Coronary angiography, however, is an
nsensitive measure of atherosclerosis burden (2),
nd some have hypothesized that subclinical ath-
rosclerosis may promote microvascular dysfunction
See page 74
nd ischemia in women with angina in the absence
f obstructive epicardial coronary disease (3). Pres-
ntly, there are few data regarding the relationship
etween angina and subclinical atherosclerosis in
women to evaluate this hypothesis.
In women with angina but without
angiographic obstructive coronary artery
disease (CAD), recent studies have re-
vealed the considerable morbidity suffered
by these women despite low overall mor-
tality. In the Women’s Ischemia Syn-
drome Evaluation study, 46% of women
with chest pain and negative coronary
angiograms had continued anginal symp-
toms at 5-year follow-up, and 20% had
symptoms severe enough for rehospitaliza-
tion. Additionally, lifetime angina-related
healthcare costs for a woman in this pop-
ulation were estimated to be $700,000
(1). Despite the significant morbidity ac-
companying this illness, the determinants
of angina in women without obstructive
CAD are still poorly defined (4). Most
tudies evaluating this entity are limited by small
ample sizes and referral bias inherent in studying
ohorts of patients referred for angiography on
linical grounds. Given the high negative predictive
alue of normal coronary artery calcium (CAC)
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artment of Internal Medicine, University of Texas Southwestern Med-
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010, accepted October 12, 2010.cans for obstructive CAD (5), coupling CAC
canning and angina data in a population-based
ohort can provide novel insights into this entity.
The objectives of this study are twofold: 1) to
ssess the relationship between angina and subclin-
cal atherosclerosis in women; and 2) to evaluate the
linical and biological factors associated with an-
ina in women without CAC in a multiethnic,
opulation-based sample.
E T H O D S
tudy population. The Dallas Heart Study is a
ultiethnic, population-based, probability sample
f subjects in Dallas County designed to examine
ardiovascular disease. Details of study design and
ariable definitions have been published previously
6). African-American subjects were deliberately
versampled to constitute 50% of the study popu-
ation. All participants provided written informed
onsent to participate in the study, and the protocol
as approved by the institutional review board of
he University of Texas Southwestern Medical
enter at Dallas. Briefly, the first in-home visit
omprised 6,101 participants ages 18 to 65 years
ho completed a detailed interview with attainment
f demographic and medical history. Subjects be-
ween the ages of 30 years and 65 years who
ompleted the initial visit were invited to participate
n a second visit, which included 3,398 who pro-
ided fasting venous blood and urine samples.
ubsequently, 2,971 participants returned for vari-
us imaging procedures including cardiac electron-
eam computed tomography (EBCT) scanning and
agnetic resonance imaging during a third visit.
here were no significant differences in demo-
raphics and clinical variables between subjects
articipating in the 3 visits (6). Sampling weights,
eflecting the different probabilities of selection for
articipants and sample attrition between visits,
ere constructed to generate unbiased estimates of
opulation frequencies (6). The present analyses
ere restricted to Caucasian, African-American,
nd Hispanic women who completed the Rose
ngina questionnaire (n  1,866) and had inter-
retable EBCT scans (n  1,502). Subjects with
elf-described ethnicity as “other” (n  22) were
xcluded from the analyses as the validity of the
ose angina questionnaire in these groups is
ncertain.
ose angina questionnaire. Angina was determined
sing the complete World Health OrganizationB B R E V I A T I O N S
N D A C R O N YM S
C aortic compliance
AC coronary artery calciu
AD coronary artery disea
RP C-reactive protein
BCT electron-beam
omputed tomography
HMI family history of
yocardial infarction
CPmonocyte
hemoattractant protein
ICAM soluble intercellula
dhesion molecule
VCAM soluble vascular c
dhesion moleculeose angina questionnaire (7). Definite Rose an-
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67ina was defined per standard criteria as having all
f the following: 1) pain or discomfort in the chest;
) onset with walking fast or uphill, or walking at an
rdinary pace on a level surface; 3) causing the
articipant to stop or slow down; 4) relieved with
esting; 5) within 10 min or less; and 6) located
long the sternum (any level) or the left anterior
hest and left arm. Participants providing a negative
esponse to any of these items were categorized as
ot having angina per the Rose definition.
ardiac EBCT. Cardiac EBCT scans were performed
n duplicate to determine CAC scores as previously
escribed (8). The CAC score was reported as the
ean score in Agatston units of 2 scans done in
mmediate succession, and prevalent CAC was
lassified as an average CAC score above 10, which
as the data-derived threshold that maximized
ignal-to-noise ratio and reproducibility between
he 2 EBCT scans (8).
ortic plaque. Abdominal magnetic resonance im-
ging was performed using a 1.5-T whole-body
ystem (Intera, Philips Medical Systems, Best, the
etherlands). Six transverse slices of the infrarenal
bdominal aorta were obtained using a free-
reathing, electrocardiography-gated, T2-weighted
urbo spin-echo (black-blood) sequence as de-
cribed previously (9). Abdominal aortic plaque was
dentified as hyperintense signal volume that pro-
ruded1 mm from the endoluminal surface of the
ortic wall as previously defined.
ortic compliance. Cardiac magnetic resonance was
erformed on the same scanner using a body coil
ith electrocardiography gating. Aortic cross-
ectional area was then measured on the axial
mages at the level of the pulmonary bifurcation
Figure 1. Relationship Between Angina and Measures of Subclin
There was no association between angina and either coronary arter
plaque as measured by magnetic resonance imaging (p  0.9).sing the QFLOW software package (version 4.1.6,
edis Medical Imaging Systems, Leiden, the
etherlands), and aortic slice volume was calculated
s the aortic cross-sectional area multiplied by the
ortic slice thickness as previously described (10).
rm blood pressure measurements were obtained at
he time of the scan using an automated Welch-
llyn sphygmomanometer, and pulse pressure was
hen calculated as systolic blood pressure minus
iastolic blood pressure. Aortic compliance (AC)
ml/mm Hg) was calculated using the following
ormula: (maximum aortic slice volume minus min-
mum aortic slice volume) divided by pulse pressure.
easurement of biomarkers. Venous blood samples
ere obtained after an overnight fast in ethylenedia-
inetetraacetic acid tubes and were stored for4 h at
°C before processing. Plasma aliquots were frozen at
80°C until assays were performed. Soluble intercel-
ular adhesion molecule (sICAM)-1, soluble vascular
ell adhesion molecule (sVCAM)-1 (11), high-
ensitivity C-reactive protein (CRP) (12), and
onocyte chemoattractant protein (MCP)-1 (13)
ere measured as previously described.
ther Variable deﬁnitions. Variable definitions for
raditional cardiovascular disease risk factors (13)
nd left ventricular hypertrophy (14) have been
reviously described. Premature family history of
yocardial infarction (FHMI) was defined using a
ore restrictive definition to ensure the sensitivity
f our premature family history variable, and in-
luded a myocardial infarction in a first-degree
elative 50 years of age for men and 55 years of
ge for women. Metabolic syndrome was defined
ccording to the National Cholesterol Education
rogram, Adult Treatment Panel III guidelines, as
l Atherosclerosis
lcium (CAC) 10 Agatston units (p  0.2) or abdominal aorticica
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68he presence of 3 of 5 standard criteria. Meno-
ause was determined by self-reported history of
enopause, 1 year from last menstrual cycle, or
istory of bilateral oopherectomy/ovariectomy.
edentary lifestyle was defined as persons with
eisure time physical activity of 0 metabolic equiv-
lents per week. Low education was defined as less
han completion of high school. Ethnicity was
etermined by self-report. Insulin resistance was
alculated according to the homeostasis model
ssessment-insulin resistance (15).
tatistical analyses. Categorical data are presented as
roportions, and continuous data as mean values
ith standard deviations or median values with
nterquartile ranges. Sample weight adjustment was
sed to estimate the population prevalence of an-
ina in women in Dallas County. Statistical com-
arisons of the prevalence of CAC and abdominal
Table 1. Risk Factors for Angina Compared With Risk Factors fo
Angina ()/CA
(n  1,179
Demographic variables
Age* 43.5 (9.0)
African-American ethnicity 48.5
Hispanic ethnicity 20.2
Low education 18.7
Traditional risk factors
Hypercholesterolemia, % 9.8
Elevated triglycerides, % 7.8
Low HDL-C, % 43.3
Diabetes mellitus, % 8.14
Smoking, % 22
Hypertension, % 23.8
LVH, % 7.4
FHMI, % 30.5
Obesity and other risk factors
Body mass index, kg/m2* 30.7 (7.1)
WC, inches* 95.3 (16.0)
Waist-to-hip ratio* 0.86
Homeostatic model assessment-insulin resistance* 3.9 (3.9)
Metabolic syndrome, % 33.3
Sedentary lifestyle, % 41.5
Post-menopausal, % 41.7
Oral estrogen, % 81.2
CRP† 3.6 (1.5–7.7
Medications
Aspirin, % 6.7
Statin, % 4.0
Antihypertensive, % 16.6
The p values were not adjusted for multiple comparisons. *Data presented as m
0.01 compared to angina negative, CAC negative. §Denotes p values 0.05 c
CAC  coronary artery calcium; CRP  C-reactive protein; FHMI  premature f
LVH  left ventricular hypertrophy; WC  waist circumference.ortic plaque in participants with and without
ngina were made using the chi-square test. Partic-
pants were categorized into 4 groups according to
he presence or absence of angina and the presence
r absence of CAC: 1) normal group (angina [],
AC []); 2) angina group (angina [], CAC
]); 3) CAC group (angina [], CAC []); and
) angina/CAC group (angina [], CAC []).
airwise comparisons were performed using the
hi-square test for categorical variables and the t
est for continuous variables. All variables associated
ith angina in those without CAC (angina [],
AC []) compared with the normal group (an-
ina [], CAC []) in univariable analyses with a
value  0.1 were tested in multivariable logistic
egression models to determine the independence
f association. As body mass index, waist circum-
erence (WC), and waist-to-hip ratio are collinear,
ronary Artery Calcium
) Angina ()/CAC () Angina ()/CAC () Angina ()/CAC ()
(n  92) (n  204) (n  22)
43.5 (8.7) 54.1 (6.7)‡ 53.5 (6.7)‡
65.2‡ 56.9§ 90.9‡
17.4 10.3§ 4.6
22.8 26§ 50‡
12 27‡ 27.2§
6.7 11.5 15
44.6 47.1 31.8
12 24.5‡ 27.3‡
22.8 41.7‡ 38.1
37‡ 59.6‡ 90.9‡
12.1 19.8‡ 35.3‡
41.3§ 52.5‡ 54.6§
32.8 (7.0)‡ 31.9 (7.8)§ 33.2 (7.7)
100.4 (14.7)‡ 101.1 (16.9)‡ 105.4 (14.6)‡
0.88‡ 0.89‡ 0.91‡
4.7 (3.7)§ 5.0 (5.0)‡ 5.5 (5.7)
46.7‡ 56.2‡ 50
40.2 49.5§ 50
54.3§ 84.7‡ 81‡
77.3 74§ 71.4
4.8 (2.3–9.0)‡ 4.9 (2.2–12.1)‡ 8.5 (2.4–12.3)‡
6.8 15.3‡ 23.8‡
9.1§ 16.8‡ 23.8‡
27.2§ 45.9‡ 90.5‡
value (SD). †Data presented as median (interquartile range). ‡Denotes p values
ared to angina(), CAC().
history of myocardial infarction; HDL-C  high-density lipoprotein cholesterol;r Co
C (
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69C alone was chosen for these models because of
ts higher Wald chi-square value. Separate models
ere created using either WC and hypertension, or
etabolic syndrome, given the redundancy in these
ariables. The relationship between angina and num-
er of metabolic syndrome components was assessed
sing the chi-square trend test. The association of
ICAM-1, sVCAM-1, CRP, MCP-1, and AC with
ngina was assessed using the Wilcoxon rank-sum test
nd also in multivariable logistic regression models
ontrolling for variables independently associated with
ngina from the models above.
E S U L T S
he overall study cohort of 1,480 women (mean age
5 years, range 30 to 65 years; 49% African-
merican, 30% Caucasian, 20% Hispanic) had a
igh prevalence of traditional CAD risk factors
25% smokers, 11% diabetes mellitus, 30% hyper-
ension, 13% hypercholesterolemia) consistent with
multiethnic, urban population. The sample
eight-adjusted prevalence of angina in the entire
ohort was 6.9%. In univariable analyses, angina
as not associated with either CAC (p  0.2) or
bdominal aortic plaque (p  0.9) (Fig. 1). These
elationships remained unchanged after age and
thnicity adjustment.
Among women without CAC, the sample-
eight adjusted prevalence of angina was 5%. Com-
ared with normal subjects (angina [], CAC
]), those with angina (angina [], CAC [])
ere more commonly African-American and post-
enopausal, and had a higher prevalence of hyper-
ension, metabolic syndrome, FHMI, as well as
igher values for body mass index, waist-to-hip
atio, WC, and insulin resistance (Table 1). We also
bserved a stepwise increase in the prevalence of
ngina with increasing number of metabolic syn-
rome factors (p trend  0.003) (Fig. 2). However,
ther traditional risk factors for atherosclerosis such
s age, dyslipidemia, diabetes, and smoking were
ot associated with angina in the absence of CAC
angina [], CAC []). In contrast, among sub-
ects with CAC who did not have angina (angina
], CAC []), most traditional atherosclerotic
isk factors were more frequent in this group com-
ared with normal subjects (Table 1). The few
ubjects with both angina and CAC (n  22) were
redominantly African-American, had the highest
revalence of many traditional risk factors, and hadarger values for adiposity measures.In multivariable analyses, only African-American
thnicity, FHMI, and WC were independently
ssociated with angina in women without CAC
Table 2). When metabolic syndrome was substi-
uted for WC and hypertension in these models,
here was a trend toward an association with angina
odds ratio: 1.54, 95% confidence interval: 0.98 to
.41).
Subjects with angina in the absence of CAC
angina [], CAC []) had higher levels of
ICAM-1 and sVCAM-1 compared with normal
ubjects (Table 3). In contrast, CRP and MCP-1
ad no independent relationship with angina. An-
ina in the absence of CAC was also associated
ith lower mean AC (22 ml/mm Hg vs. 26 ml/mm
g, p  0.007). The associations of angina with
ICAM-1, sVCAM-1, and AC remained statisti-
ally significant when controlling for variables in-
ependently associated with angina. Applying
ppropriate statistical transformations of these vari-
Figure 2. Relationship Between Angina and Number of Metabo
Syndrome Factors
The prevalence of angina increases in a stepwise fashion as the num
metabolic syndrome factors increase, p trend  0.003. Metabolic sy
factors include waist circumference 35 inches, triglycerides 150
high-density lipoprotein cholesterol 50 mg/dl, blood pressure 1
mm Hg, and fasting glucose 100 mg/dl.
Table 2. Multivariable Analyses of Variables Independently Ass
in Women Without CAC
Model 1
OR (95% CI) p Value OR (
African-American ethnicity 2.2 (1.2–3.9) 0.01 2.2 (1
FHMI 2.7 (1.5–4.7) 0.01 2.7 (1
Increased WC, 35 inches 1.8 (1.1–3.1) 0.03
Metabolic syndrome — — 1.5 (0
Model 1 included all variables from Table 1 with p value 0.1, including WC an
metabolic syndrome. Model 2 included all variables from Table 1 with p value 
syndrome, but not WC or hypertension.lic
ber of
ndrome
mg/dl,
30/85ociated With Angina
Model 2
95% CI) p Value
.2–3.9) 0.01
.5–4.7) 0.01
— —
.98–2.4) 0.06
d hypertension, but not
0.1, including metabolicCI  conﬁdence interval; OR  odds ratio; other abbreviations as in Table 1.
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70bles to create normal distributions did not mate-
ially change the results. In subjects with CAC,
ngina had no statistical association with sICAM-1,
VCAM-1, or AC (Table 4).
I S C U S S I O N
n this large multiethnic population-based sample
f women, angina was reported by approximately
% of women ages 30 to 65 years but was not
ssociated with subclinical atherosclerosis. The
ariables related to angina in women without CAC
iffered from the traditional spectrum of risk factors
ssociated with atherosclerosis, and favored obesity
nd insulin resistance factors as well as African-
merican ethnicity, FHMI, measures of endothe-
ial dysfunction, and large artery stiffness. These
ndings suggest that angina in absence of athero-
clerosis may be a distinct entity from atheroscle-
otic cardiovascular disease, and that vascular dys-
unction may play a more prominent role in the
nderlying pathophysiology of this syndrome.
ngina and coronary and peripheral subclinical athero-
clerosis. We found no association between angina
nd CAC in our cohort of relatively young women.
of Inﬂammatory Biomarkers and Aortic Compliance With
ithout CAC
gina ()/CAC ()
(n  1,179)
Angina ()/CAC ()
(n  92)
Unadjusted
p Value
Adjusted
p Value*
592 (452–813) 668 (510–903) 0.02 0.002
968 (704–1,353) 1,106 (833–1,444) 0.01 0.002
3.6 (1.5–7.7) 4.8 (2.3–9) 0.04 0.5
157 (105–229) 163 (118–218) 0.9 0.9
26 (12) 22 (11) 0.007 0.007
I, and WC. †Data presented as median values (interquartile range). ‡Data
s (SD).
e; MCP  monocyte chemoattractant protein; sICAM  soluble intracellular
M  soluble vascular cell adhesion molecule; other abbreviations as in Table 1.
of Inﬂammatory Biomarkers and Aortic Compliance With
ith CAC
gina ()/CAC ()
(n  204)
Angina ()/CAC ()
(n  22)
Unadjusted
p Value
Adjusted
p Value*
613 (487–839) 703 (568–1,053) 0.1 0.1
1023 (800–1,420) 1134 (876–2,067) 0.2 0.5
4.9 (2.2–12.1) 8.5 (2.4–12.3) 0.4 0.7
176 (136–234) 230 (199–367) 0.03 0.01
14.6 (9.5) 13 (11.0) 0.7 0.8
WC. †Data presented as median values (interquartile range). ‡Data presented asb
s 1 and 3.ur results are somewhat discordant with those
rom the Rotterdam Study, the only other large
pidemiological study to investigate the association
etween angina and CAC. In this population-based
ohort study performed in the Netherlands, women
ith angina had a 4.8 increased odds of CAC
1,000 Agatston units compared with women
ithout angina (16). These discrepant results are
ikely due in part to the much older age, higher
verall prevalence and severity of CAC, and evalu-
tion of the amount of calcium rather than the
resence of calcium in the Rotterdam study.
Our null results with CAC do not exclude the
ossibility that angina is associated with “soft,”
oncalcified atherosclerotic plaque in women that
ay be present in approximately 6% of those
ithout CAC (17). Accordingly, we evaluated the
elationship between angina and magnetic reso-
ance imaging measured abdominal aortic plaque, a
oncalcific measure of atherosclerosis in a second
ascular territory, and also failed to observe any
ignificant associations with angina prevalence.
hese findings suggest that subclinical atheroscle-
osis, whether calcified or noncalcified, is not likely
major contributor to angina among relatively
oung women in the general population.
linical determinants of angina in women without
bstructive CAD. Investigating the determinants of
ngina in women without obstructive CAD is
hallenging, and prior studies in this area have
eported inconsistent results. While some studies
eveal associations with traditional cardiovascular
isease risk factors, menopausal status, and ethnic-
ty, others do not. Despite these inconsistencies,
ost studies suggest a prominent role of endothelial
ysfunction in the underlying pathophysiology (18).
Our study used a novel model to define angina
ithout obstructive CAD in a population-based
ohort, Rose angina without CAC. This algorithm
pplies a validated measure of angina to a popula-
ion free from referral bias, and one with negligible
oronary atherosclerosis. We found that most tra-
itional risk factors for atherosclerosis were not
ssociated with angina in women without CAC;
otably, there was no association with hypercholes-
erolemia, smoking status, or age. In contrast,
everal variables reflecting insulin resistance and
besity were related to this entity, including an
ndependent association with WC as well as a
tepwise association with a greater number of met-
bolic syndrome factors. Increased WC and meta-Table 3. Association
Angina in Women W
An
sICAM-1, ng/ml†
sVCAM-1, ng/ml†
CRP, mg/l†
MCP-1, pg/ml†
AC, ml/mm Hg‡
*Adjusted for race, FHM
presented as mean value
AC  aortic compliancTable 4. Association
Angina in Women W
An
sICAM-1, ng/ml†
sVCAM-1, ng/ml†
CRP, mg/l†
MCP-1, pg/ml†
AC, ml/mm Hg‡
*Adjusted for race, FHMI,
mean values (SD).olic syndrome both correlate with higher amounts of
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71isceral adiposity, which in turn has been linked to
mpaired endothelial function as measured by de-
reased brachial artery flow-mediated dilation (19).
Our findings regarding the association of
frican-American ethnicity, FHMI, and WC with
ngina are consistent with a recent report from the
omen’s Ischemia Syndrome Evaluation study in-
estigators (20), although that study derived from a
eferral population that may have had higher prev-
lence of cardiovascular risk factors and did not
mploy multivariable adjustment. As with WC,
frican-American ethnicity and FHMI have also
een correlated with endothelial dysfunction.
frican-Americans have decreased flow-mediated
ilation (21) and increased levels of endothelin-1, a
otent vasoconstrictor released by the endothelium,
ompared with Caucasians (22). Further, the pro-
ective effect of female sex on endothelial function is
ess evident in African-Americans compared with
aucasians (23). A study of offspring from patients
ith FHMI also revealed decreased flow-mediated
ilation compared with healthy controls (24).
iomarkers of endothelial dysfunction and aortic
ompliance. Both sICAM-1 and sVCAM-1 are
nflammatory biomarkers that are indicative of en-
othelial dysfunction. Turhan et al. (25) evaluated
ICAM-1 and sVCAM-1 levels in subjects with no
oronary atherosclerosis and either normal or ab-
ormal coronary blood flow and found that
ICAM-1 and sVCAM-1 levels were higher in
hose with lower flow. These results suggest that
ncreased levels of soluble adhesion molecules and
oncomitant endothelial dysfunction may result in
low coronary flow, a known precipitant of ischemia
nd angina in those with normal coronary arteries
26). In contrast to sICAM-1 and sVCAM-1, CRP
nd MCP-1 are nonspecific inflammatory markers,
nd the lack of association of CRP and MCP-1
ith angina in our study indicates that the findings
ith sICAM-1 and sVCAM-1 are not just reflec-
ive of generalized information. However, the null
ndings with CRP could be the result of reverse
onfounding by higher statin medication use in
atients with angina.
Reduced AC may be related to angina in
omen without CAC either because of a shared
athophysiology with endothelial dysfunction or
ecause of a direct causal association. Several
tudies have demonstrated correlations between
easures of large artery stiffness and endothelial
ysfunction (27). Some researchers have hypoth-
sized that endothelial dysfunction in the vaso-
asorum may lead to ischemia in parts of the torta resulting in stiffening. Aortic stiffening, in
urn, could lead to abnormal ascending aortic
ow, reduced coronary artery flow, and ischemia
28). Alternatively, reduced AC may be associ-
ted with increased afterload causing a widened
ulse pressure, decreased diastolic coronary per-
usion pressure and angina in this population.
linical implications. Our study findings suggest that
ngina in women is unrelated to subclinical athero-
clerosis. Moreover, many traditional risk factors for
therosclerosis do not associate with angina in
omen without CAC. Thus, attempting to target
tandard atherosclerosis risk factors may not be an
ffective strategy for reducing the angina-related
orbidity experienced by these women. In contrast,
ncreased levels of sICAM-1 and sVCAM-1, and
ower AC independently associated with angina in
his population, and each of these factors could
lausibly play a direct causal or contributory role in
his syndrome. Therefore, therapies that favorably
mpact endothelial dysfunction and vascular stiffness
uch as L-arginine (29), angiotensin-converting en-
yme inhibitors, and statins may prove to be effica-
ious. The association with abdominal obesity in our
nalyses suggests that weight loss could also have
alutary effects on angina in this population. Finally,
hese findings should heighten awareness of the in-
reased prevalence of the syndrome of angina without
bstructive CAD among African-Americans and
mong persons with a FHMI, a possible treatable
iagnosis in those with chest pain complaints.
tudy limitations. The present study used the Rose
ngina questionnaire rather than a clinician eval-
ation or diagnostic studies to define angina.
owever, the Rose angina questionnaire has been
xtensively validated and used in numerous epi-
emiologic studies of angina (30). In addition,
hysician-diagnosed angina may not be reflective
f the true burden and nature of angina in the
eneral population. Indeed, our definition of
ngina may be a more “pure” form of angina that
s free from selection biases or confounding by
ubclinical atherosclerosis. The small numbers of
articipants with angina defined by the Rose
ngina questionnaire (n  112) yields little power
o rigorously assess associations, potentially yield-
ng type 2 error. Despite this limitation of power,
e found consistent associations between Rose
ngina and patterns of clinical and biological
actors, suggesting that the Rose angina ques-
ionnaire is a valid measure that is quantifying a
rue clinical entity.
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72O N C L U S I O N S
ypical exertional angina affects 1 of every 14
omen between the ages of 30 and 65 years in
allas County. Interestingly, angina was not
ssociated with subclinical atherosclerosis among
omen. Angina that occurs in the absence of
ubclinical atherosclerosis was not related to
any traditional atherosclerotic risk factors;9. Khera A, de Lemos JA, Peshock RM,
et al. Relationship between C-reactive raphy in patients wiascular stiffness and endothelial dysfunction,
uggesting a distinct vascular etiology and alter-
ate potential therapeutic targets for this entity
ompared with atherosclerosis.
eprint requests and correspondence: Dr. Amit Khera,
ivision of Cardiology, University of Texas Southwest-
rn Medical Center, 5909 Harry Hines Boulevard, Room
A9.133, Dallas, Texas 75390-9047. E-mail: amit.khera@however, it was associated with measures of utsouthwestern.edu.1
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